Broad proteomics analysis using in vitro models of Parkinson's disease shows molecular signatures associated with disease progression and identifies potential disease modulatorsCasey J. Lumpkin(Gettysburg College)UnknownJanuary 1, 202310.17760/d20560785Cited by 0SaveCiteExport RISWatch citationsRelated PapersEvaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy|Scientific Reports|2023|9Broad proteomics analysis of seeding-induced aggregation of α-synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson’s disease pathogenesis|Molecular Brain|2024|4